The new BEMER treatment system represents the most researched and most effective physical treatment method used in complementary and preventative medicine today.
The new BEMER signal has been developed even further and modified according to the latest findings on the biorhythm of local and primary regulatory processes associated with microcirculation (physical treatment method). It now stimulates the restricted or impaired microcirculation of organs even better than before.
The specific temporary signal order and structure of the electromagnetic field with a low flux density are crucial in effectively stimulating the mechanism for regulating microcirculation.
PatentsEP-B-0995463, WO 2008/025731 A1, WO 2011/023634 A1 and WO 2011/023635
BEMER is an officially approved medical device in EU, class IIa (93/42EEC ja CE0483).
During the past 15 years, 46 publications have been developed and there are four scientific studies about BEMER therapy in PubMed (http://www.ncbi.nlm.nih.gov/pubmed/).
Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
Ziemssen T, Piatkowski J, Haase R.
Altern Ther Health Med. 2011 Nov-Dec;17(6):22-8.
Synergistic effect of EMF-BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma.
Říhová B, Etrych T, Šírová M, Tomala J, Ulbrich K, Kovář M.
J Drug Target. 2011 Dec;19(10):890-9. Epub 2011 Oct 10.
Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis: a randomized, double-blind controlled trial.
Piatkowski J, Kern S, Ziemssen T.
J Altern Complement Med. 2009 May;15(5):507-11.
Effects of weak, low-frequency pulsed electromagnetic fields (BEMER type) on gene expression of human mesenchymal stem cells and chondrocytes: an in vitro study.
Walther M, Mayer F, Kafka W, Schütze N.
Electromagn Biol Med. 2007;26(3):179-90.
For more information if necessary:
Medical support, BEMER International AG, Liechtenstein medical[at]bemergroup.com